Xuandan Qingjin Granule Reversing Osimertinib Resistance by Inhibiting Tumor
 Stem Cells Through Hh-Ptch/Smo-Gli Regulatory Axis

doi:10.3870/j.issn.1672-0741.24.09.008

Acta Medicinae Universitatis Scientiae et Technologiae Huazhong ›› 2025, Vol. 54 ›› Issue (1): 52-59.doi: 10.3870/j.issn.1672-0741.24.09.008

Previous Articles Next Articles

Xuandan Qingjin Granule Reversing Osimertinib Resistance by Inhibiting Tumor Stem Cells Through Hh-Ptch/Smo-Gli Regulatory Axis

Received:2024-09-04 Online:2025-02-15 Published:2025-03-05

Abstract

CLC Number:

R734.2

Li Yang, Liu Lei, Lin Jiamao. Xuandan Qingjin Granule Reversing Osimertinib Resistance by Inhibiting Tumor Stem Cells Through Hh-Ptch/Smo-Gli Regulatory Axis[J]. Acta Medicinae Universitatis Scientiae et Technologiae Huazhong, 2025, 54(1): 52-59.

[1]	Wang Yun, Shu Yang, Wu Xiaobai, et al. Expression of NPM3 in Lung Adenocarcinoma and Its Impact on the Biological Function of Lung Adenocarcinoma Cell [J]. Acta Medicinae Universitatis Scientiae et Technologiae Huazhong, 2025, 54(1): 36-44.
[2]	Wu Fan, Li Ya, Liu Xingyue, et al. Inhibitory Effect of IL-9 on Growth of Lung Adenocarcinoma Graft Tumor and Its Action Mechanism [J]. Acta Medicinae Universitatis Scientiae et Technologiae Huazhong, 2024, 53(4): 438-443.
[3]	. [J]. Acta Medicinae Universitatis Scientiae et Technologiae Huazhong, 2023, 52(4): 482-488.
[4]	. [J]. Acta Medicinae Universitatis Scientiae et Technologiae Huazhong, 2022, 51(5): 601-606.

Xuandan Qingjin Granule Reversing Osimertinib Resistance by Inhibiting Tumor Stem Cells Through Hh-Ptch/Smo-Gli Regulatory Axis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 4

Recommended Articles

Metrics

Comments